Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1996-12-11
1999-02-09
Davenport, Avis M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 17, 514 14, 514 15, 530323, 530324, 530325, 530326, 530327, A61K 3800, A61K 3802, C07K 500, C07K 700
Patent
active
058694510
ABSTRACT:
Described are peptides and peptide mimetics that bind to and activate the thrombopoietin receptor. Such peptides and peptide mimetics are useful in methods for treating hematological disorders and particularly, thrombocytopenia resulting from chemotherapy, radiation therapy, or bone marrow transfusions as well as in diagnostic methods employing labeled peptides and peptide mimetics.
REFERENCES:
patent: 5143854 (1992-09-01), Pirrung et al.
patent: 5198424 (1993-03-01), McEver
patent: 5270170 (1993-12-01), Schatz et al.
patent: 5326558 (1994-07-01), Turner et al.
patent: 5338665 (1994-08-01), Schatz et al.
patent: 5384331 (1995-01-01), Kogan et al.
Barker et al., (1992) J. Med. Chem. 35:2040-2048 Cyclic RGD peptide analogues as antiplatelet antithrombotics.
Bartley et al., (1994) Cell 77: 1117-1124 Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl.
Bazan (1990) Proc. Natl. Acad. Sci. USA 87:6934-6938 Structural design and molecular evolution of a cytokine receptor superfamily.
Caras et al., (1989) Science 243:1169-1198 Signal peptide for protein secretion directing glycophospholipid membrane anchor attachment.
Cwirla et al., (1990) Proc. Natl. Acad. Sci. USA 87:6378-6382 Peptides on phage: A vast library of peptides for identifying ligands.
Dexter et al., (198) J. Exp. Med. 152:1036-1047 Growth factor-dependent hemopoietic precursor cell lines.
Dower et al., (1988) Nucleic Acids Research 16:6127 High efficiency transformation of E. coli by high voltage electroporation.
Dower et al., (1991) Ann. Rep. Med. Chem. 26:271-280 The search for molecular diversity (II): Recombinant and synthetic randomized peptide libraries.
Fodor et al., (1991) Science 251:767-773 Light-directed, spatially addressable parallel chemical synthesis.
Harker (1968) J. Clin. Invest. 47:458-465 Kinetics of thrombopoiesis.
Hession et al. (1990), Proc. Acad. Sci. USA 87:1673-1677 Endothelial Leukocyte adhesion molecule 1: Direct expression cloning and functional interactions.
Kojima et al. (1995) J. Biol. Chem. 270:21984-21990 Molecular cloning and expression of megakaryocye potentiating factor cDNA.
Kaushansky et al., (1994) Nature 369:568-571 Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin.
Kuter et al., (1994) Proc. Natl. Acad. Sci. USA 91:11104-11108 The purification of megapoietin: A physiological regulator of megakaryocyte growth and platelet production.
McDonald (1992) Am. J. Pediatric Hematology/Oncology 14:8-21 Thrombopoietin--Its biology, clinical aspects and possibilities.
Metcalf (1994) Nature 369:519-520 Thrombopoietin--at last.
Methia et al., (1993) Blood 82:1395-1401 Oligodeoxynucleotides antisense to the proto-oncogene c-mpl specifically inhibit in vitro megakaryocytopoiesis.
Mossmann (1983) J. Immunol. Methods 65:55-63 Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays.
Or et al., (1991) J. Org. Chem. 56: 3146-3149 Cysteine alkylation in unprotected peptides: synthesis of a carbavasopressin analogue by intramolecular cysteine alkylation.
de Sauvage et al. (1994) Nature 369:533-538 Stimulation of megakaryocytopiesis and thrombopoiesis by the c-Mpl ligand.
Souyri et al., (1990) Cell 63:1137-1147 A putative truncated cytokine receptor gene transduced by the myeloproliferative leukemia virus immortalizes hematopoietic progenitors.
Spertini et al., (1991) Nature 349:691-694 Regulation of leukocyte migration by activation of the leukocyate adhesion molecule-1 (LAM-1) selectin.
Veber et al., (1990) Trends in Neurosciences(TINS) pp. 392-396 The design of metabolically-stable peptide analogs.
Vigon et al., (1992) Proc Natl. Acad Sci. USA 89:5640-5644 Molecular cloning and characterization of MPL, the human homolog of the v-mpl oncogene: Identification of a member of the hematopoietic growth factor receptor superfamily.
Wendling et al., (1991) L'Inserm 145-146 The oncongene V-MPL, A putative truncated cytokine receptor which immortalizes hematopoetic progenitors.
Wendling et al., (1994) Nature 369:571-574 c-Mpl ligand is a humoral regulator of megakaryocytopiesis.
Balasubramanian Palaniappan
Barrett Ronald W.
Cwirla Steven E.
DePrince Randoph B.
Dower William J.
Davenport Avis M.
Glaxo Group Limited
Hrubiec Robert T.
Stevens Lauren L.
LandOfFree
Peptides and compounds that bind to a receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptides and compounds that bind to a receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptides and compounds that bind to a receptor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1948475